209 related articles for article (PubMed ID: 6647075)
1. [Antibiotic treatment of lung disease in cystic fibrosis].
Biasini GC; Pistocchi E; Miano A
Pediatr Med Chir; 1983; 5(4):157-60. PubMed ID: 6647075
[TBL] [Abstract][Full Text] [Related]
2. [Antibiotic treatment of cystic fibrosis].
de Montalembert M; Berche P; Lenoir G
Ann Pediatr (Paris); 1991 Oct; 38(8):523-8. PubMed ID: 1746849
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
Zabner R; Quinn JP
Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
[TBL] [Abstract][Full Text] [Related]
4. Microbiologic and therapeutic aspects of Staphylococcus aureus in cystic fibrosis patients.
Bauernfeind A; Hörl G; Przyklenk B
Scand J Gastroenterol Suppl; 1988; 143():99-102. PubMed ID: 3164518
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic use in cystic fibrosis.
Eisenberg JD
Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
[TBL] [Abstract][Full Text] [Related]
8. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
9. Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.
Cahen P; Le Bourgeois M; Delacourt C; Coustère C; Nicaise P; de Blic J; Véron M; Scheinmann P; Gaillard JL
Pediatrics; 1993 Feb; 91(2):451-5. PubMed ID: 8424026
[TBL] [Abstract][Full Text] [Related]
10. [Bacterial infections and resistance to antibiotics in cystic fibrosis].
Taccetti G; Repetto T; Procopio E; Marianelli L; Campana S
Pediatr Med Chir; 1999; 21(5 Suppl):213-8. PubMed ID: 10963010
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations.
Keays T; Ferris W; Vandemheen KL; Chan F; Yeung SW; Mah TF; Ramotar K; Saginur R; Aaron SD
J Cyst Fibros; 2009 Mar; 8(2):122-7. PubMed ID: 19064337
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary infections in children with cystic fibrosis.
Stutman HR; Marks MI
Semin Respir Infect; 1987 Sep; 2(3):166-76. PubMed ID: 3317617
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing and managing infection in CF.
Ratjen F
Paediatr Respir Rev; 2006; 7 Suppl 1():S151-3. PubMed ID: 16798546
[TBL] [Abstract][Full Text] [Related]
14. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection.
Garske LA; Kidd TJ; Gan R; Bunting JP; Franks CA; Coulter C; Masel PJ; Bell SC
J Hosp Infect; 2004 Mar; 56(3):208-14. PubMed ID: 15003669
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic synergy testing should not be routine for patients with cystic fibrosis who are infected with multiresistant bacterial organisms.
Aaron SD
Paediatr Respir Rev; 2007 Sep; 8(3):256-61. PubMed ID: 17868924
[TBL] [Abstract][Full Text] [Related]
16. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic therapy in asthma exacerbation and in cystic fibrosis in children].
Breborowicz A
Pol Merkur Lekarski; 2011 May; 30(179):349-51. PubMed ID: 21675140
[TBL] [Abstract][Full Text] [Related]
18. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
Michalsen H; Bergan T
Scand J Infect Dis Suppl; 1981; 29():92-7. PubMed ID: 6947408
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis infections: treatment strategies and prospects.
George AM; Jones PM; Middleton PG
FEMS Microbiol Lett; 2009 Nov; 300(2):153-64. PubMed ID: 19674113
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
Etherington C; Hall M; Conway S; Peckham D; Denton M
J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
